Lawmakers to Question FDA, Merck Over Vioxx
23664
Merck &amp; Co. Inc. Chief Executive Officer Raymond Gilmartin and FDA officials have been called to testify before Congress on Nov. 18 over safety problems with the company&#39;s withdrawn
332433
Merck&#39;s (MRK :NYSE - news - research) decision to withdraw its popular arthritis drug Vioxx from the market in late September has raised questions about the process leading up to its regulatory approval in 1999 as well as the importance of subsequent
427635
Three drugs -- Vioxx, Ketek and Avandia -- are casting long shadows over the congressional debate on how to update and revise the 15-year-old system that has dramatically sped up the process of bringing prescription medicines to American consumers.
270368
Merck &amp; Co.&#39;s recall of the Vioxx painkiller shows why the US Food and Drug Administration needs its safety monitors to be independent of those who approve new medicines, FDA scientist David J. Graham told a Senate hearing.
399969
Merck &amp; Co. Chief Executive Officer Raymond Gilmartin will appear at a Nov. 18 Senate Finance Committee hearing into the withdrawal of the company&#39;s Vioxx painkiller, panel spokeswoman Jill Gerber said today in Washington.
108301
Federal prosecutors and the S.E.C. are investigating Merck in connection with its recalled pain reliever, Vioxx.
136905
Federal prosecutors and the Securities and Exchange Commission are investigating Merck &amp; Company in connection with Vioxx, the painkiller that was pulled from the market in late September
62492
Merck&#39;s recall of its arthritis pain drug, Vioxx, because of elevated risks of heart attack and stroke has obscured another important issue that Congress, in investigating the matter, must face squarely and deal with: What happens when pharmaceutical
137276
ROCKVILLE, Md.  - The U.S. Food and Drug  Administration on Friday asked an outside group to review the  way the agency monitors safety risks of medicines after they  hit the market, such as Merck & Co. Inc.'s withdrawn painkiller  Vioxx.
159888
ROCKVILLE, Md.  - The U.S. Food and Drug  Administration on Friday asked an outside group to review the  way it monitors safety risks associated with medicines already  on the market, such as Merck & Co. Inc.'s withdrawn painkiller  Vioxx.
496967
The House Energy and Commerce Committee is investigating how Vioxx was approved and then taken off the market. It has written to Lester Crawford, FDA, and Ray Gilmartin, CEO of Merck, requesting documents about Vioxx.
675666
WASHINGTON -- After months of heightened concerns about the safety and effectiveness of Vioxx and similar best-selling painkillers, and intense criticism of how the Food and Drug Administration has handled them, the agency will launch critical meetings beginning tomorrow on what to do next.
161932
The problems with Vioxx, taken off the market last week, raise questions about the Food and Drug Administration's safety review process. Observers say longer clinical trials should be required.
240261
Amid questions about whether the arthritis drug Vioxx was taken off the market soon enough, a key senator suggested Friday that an independent board of drug safety might be needed to ensure the safety of medications after they're approved for the market.
118917
WASHINGTON, DC - First District Congressman Marion Berry wrote to Congressional leaders today requesting the Energy and Commerce Committee hold a hearing on the Food &amp; Drug Administration&#39;s (FDA) handling of the Vioxx safety issue.
592608
Lawyers for customers suing Merck &amp; Co. want to question CEO Raymond Gilmartin about what he knew about the dangers of Vioxx before the company withdrew the drug from the market because of health hazards.
450325
U.S. health officials and drugmaker GlaxoSmithKline Plc are likely to face tough questioning from lawmakers on Wednesday over their handling of data suggesting a heart risk with the widely used diabetes pill Avandia.